Taiwan FDA registration edc385fb836e6421d350e4b66a49ffa7
Changying does not require the selection of the insulin-like growth factor II enzyme immune reagent
TW: 常盈 無需選粹胰島素樣生長因子II酵素免疫試劑組
Taiwan·Risk Class 2·DIAGNOSTIC SYSTEMS LABORATORIES, INC.·Registered Mar 23, 2006 – Mar 23, 2011CancelledRegistration details
- Analysis ID
- edc385fb836e6421d350e4b66a49ffa7
- Customs Code
- DHA00601620705
Company information
- Manufacturer
- DIAGNOSTIC SYSTEMS LABORATORIES, INC.
- Manufacturer Country
- United States
- Authorized Representative
- WOLCH ENTERPRISES INC.
Product details
- Intended Use
- 定量測定人體血清或血漿中的IGF-II.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1370 Human Growth Hormone Testing System
- Import Information
- import
Dates and status
- Registration Date
- Mar 23, 2006
- Expiry Date
- Mar 23, 2011
- Cancellation Date
- Nov 26, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Changying does not require the selection of the insulin-like growth factor II enzyme immune reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number edc385fb836e6421d350e4b66a49ffa7 and manufactured by DIAGNOSTIC SYSTEMS LABORATORIES, INC.. The authorized representative in Taiwan is WOLCH ENTERPRISES INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices